Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
6th
years
Home>>Products>>Doxorubicin CAS 25316-40-9 Doxorubicin Hydrochloride

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile: +8615207100586

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

Doxorubicin CAS 25316-40-9 Doxorubicin Hydrochloride

CAS NO.25316-40-9

  • FOB Price: USD: 20.00-20.00 /Gram Get Latest Price
  • Min.Order: 10 Gram
  • Payment Terms: T/T,
  • Available Specifications:

    AAAAA(50-200)Gram

Contact Supplier

Product Details

Keywords

  • Doxorubicin
  • Doxorubicin Hydrochloride
  • 25316-40-9

Quick Details

  • ProName: Doxorubicin CAS 25316-40-9 Doxorubicin...
  • CasNo: 25316-40-9
  • Application: Research chemical
  • DeliveryTime: Ready stock
  • PackAge: 10g/bag; 100g/bag; 1kg/bag
  • ProductionCapacity: 10 Kilogram/Month
  • Purity: 99%
  • Transportation: Room temperature
  • LimitNum: 10 Gram

Superiority

Vanz Pharm, which is specialized in custom synthesis and R&D, is located in Wuhan, China. our main products are indacaterol, carmoterol etc. We have established long-term cooperation with Shanghai Institute of Organic Chemistry, Wuhan University etc. As a special team in organic chemistry and medicinal chemistry, we support the technology of R&D on new product. We have     strong advantages on the process research and product R&D, pay attention to researching and developing new technology which is self-owned intellectual property right. We are special at developing Drug for the respiratory, antidepressant, antivirus. We have completed R&D of more than 20 APIs and intermediates after the company founded.

 

    Our R&D center covers an area of 1000 square meters, with four synthesis labs, one scale-up pilot labs and one analytical lab. The lab is equipped with complete laboratory facilities and equipment. We have a professional research team of highly qualified and experienced chemists. most of our R&D team are Master and higher. With their effort, we quickly transfer the science fruit into production. Our manufacturing site is located in Wuhan which is equipped with 100L~5000L reactors; we can offer one-stop services from R&D to commercial production. (Normal reaction/ High-pressure reaction/ Catalytic reaction/ Low-Temperature reaction).

    With great joint efforts of our staffs, Vanz is getting more market for developing and manufacturing Medicine, New Compounds, Advanced Intermediates, as well as Custom Synthesis. We will make persistent efforts, providing excellent services to our customers, perfecting R&D condition, as well as enlarging business service range. We believe Vanz will be one of the brightest star in near future with your kind support and our mutual efforts.

Details

Product Name: Doxorubicin hydrochloride
Synonyms: ADRIACIN;ADRIBLASTINA;ADRIBLASTINA HYDROCHLORIDE;ADRIAMYCIN HCL;ADRIAMYCIN HYDROCHLORIDE;(8s-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride;14-HYDROXYDAUNOMYCIN HCL;14-HYDROXYDAUNOMYCIN HYDROCHLORIDE
CAS: 25316-40-9
MF: C27H30ClNO11
MW: 579.98
EINECS: 246-818-3
Melting point: 216 °C (dec.)(lit.)
Storage temp.: 2-8°C

Description:

Doxorubicin is available as both the conventional dosageform and a liposomal preparation, both of which are administeredby infusion. Doxorubicin HCl powder is available in10-, 20-, 50-, and 150-mg vials and is widely used in treatingvarious cancers, including leukemias, soft and bone tissuesarcomas, Wilms tumor, neuroblastoma, small cell lungcancer, and ovarian and testicular cancer.

Usage:

Doxorubicin is an anthracycline antitumor antibiotic that inhibits DNA topoisomerase II by inducing double-stranded DNA breaks. By intercalating within DNA, doxorubicin inhibits nucleic acid synthesis and induces apoptosis by inducing the accumulation of the p53 tumor suppressor protein.